Document Detail


Hyperphosphataemia and hypocalcaemia induced by hypertonic phosphate enema--an experimental study and review of the literature.
MedLine Citation:
PMID:  1683549     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
1. The study objective was to determine the hyperphosphataemic and hypocalcaemic effect of hypertonic phosphate enema. The study was conducted in a department of Internal Medicine at a University Medical Center. 2. Fourteen patients were studied. Patients' mean age (+/- s.d.) was 78.5 +/- 9 years. The creatinine clearance was 48.2 +/- 17.4 ml min-1 (mean +/- s.d.). 3. 500 ml (approx. 7 ml kg-1) of Fleet enema (FE - Na2HPO4.7H2O 224 mmol l-1 and NaH2PO4.H2O 1160 mmol l-1) were administered to each patient. Blood was drawn before FE administration and 1/2, 1, 3, 5, 12 and 24 h thereafter. Serum was analysed for levels of inorganic phosphorus and for calcium. 4. The serum inorganic phosphorus level rose from 1.01 +/- 0.3 mmol l-1 to 1.4 +/- 0.5 mmol l-1 (P = 0.001) 1 h after FE was administered. Serum calcium decreased from 2.32 +/- 0.12 mmol l-1 to 2.12 +/- 0.1 mmol l-1 (P less than 0.001) 12 h after FE was administered. 5. We conclude that FE carries a potential risk for acutely ill elderly patients. To avoid untoward effects due to hyperphosphataemia and hypocalcaemia, the phosphate load must be adjusted to the patient's renal function, i.e. enema volume is to be lowered when phosphate concentration is high, so that if renal function is compromised the amount of phosphate absorbed does not exceed renal excretion capacity.
Authors:
I Grosskopf; E Graff; G Charach; G Binyamin; S Spinrad; I Blum
Related Documents :
12005179 - Effect of intravenous bisphosphonates on release of basic fibroblast growth factor in s...
6715089 - Nifedipine plasma concentration in patients treated for angina pectoris.
8538929 - Effect of gastric acid secretion on intestinal phosphate and calcium absorption in norm...
22395269 - Effect of match importance on salivary cortisol and immunoglobulin a responses in elite...
2807779 - Investigation of gags on 24-hour and 2-hour urines from calcium oxalate stone formers a...
12474069 - The effects of calcium supplementation to patients with primary hyperparathyroidism and...
6647889 - The effect of atropine on bombesin and gastrin releasing peptide stimulated gastrin, pa...
9027569 - Supplemental dietary chromium does not influence acth, cortisol, or immune responses in...
2618819 - The importance of protein content in the oedema fluid for the resolution of brain oedema.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Human & experimental toxicology     Volume:  10     ISSN:  0960-3271     ISO Abbreviation:  Hum Exp Toxicol     Publication Date:  1991 Sep 
Date Detail:
Created Date:  1992-01-08     Completed Date:  1992-01-08     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  9004560     Medline TA:  Hum Exp Toxicol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  351-5     Citation Subset:  IM    
Affiliation:
Department of Internal Medicine C, Rokach Hospital, Tel-Aviv, Israel.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aged
Child
Child, Preschool
Enema / adverse effects*
Female
Humans
Hypertonic Solutions
Hypocalcemia / chemically induced*
Infant
Male
Middle Aged
Phosphorus / blood*
Chemical
Reg. No./Substance:
0/Hypertonic Solutions; 7723-14-0/Phosphorus

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Distribution and elimination of [2-14C]amino-3,8-dimethylimidazo [4, 5-f] quinoxaline in mice. Analy...
Next Document:  In-vitro hepatotoxicity of three dichlorobenzene isomers in human liver slices.